摘要
血管生成抑制素 (angiostatin ,AS)是近几年发现、命名的血管生成抑制因子 ,在肿瘤的治疗方面具有潜在的应用前景 ,对AS的研究已取得了较多成果 ,本文就AS在基础和临床前研究的最新近展作一综述。
出处
《国外医学（临床生物化学与检验学分册）》
2001年第1期14-15,共2页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献10
-
1Barendsz-Janson AF,Griffioen AW,Muller AD,et al.In vitro tumor angiogenesis assays: plasminogen lysine binding site 1 inhibits in vitro tumor-induced angiogengsis[].Journal of Vascular Research.1998
-
2O′Mahony CA,Albo D,Tuszynski GP,et al.Transforming growth factor-betal 1 inhibits generation of angiostatin by human pancreatic cancer cells[].Journal of Surgery.1998
-
3Cao Y.Therapeutic potentials of angiostatin in the treatment of cancer[].Haematologia.1999
-
4Walter JJ,Sane DC.Angiostatin binds to smooth muscle cells in the coronary artery and inhibits smooth muscle cell proliferation and migration in vitro[].Arteriosclerosis and Thrombosis.1999
-
5Cao Y,O′Reilly MS,Marshall B,et al.Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases[].The Journal of Clinical Investigation.1998
-
6De Schryver A,Verh K.Waiting for the break through: a few tentative scenarios for cancer prevention and treatment in the coming decades[].Acad Geneeskd Belg.1999
-
7Ji WR,Barrientos LG,Llinas M,et al.Sclective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis[].Biochemical and Biophysical Research Communications.1998
-
8Dong Z,Yoneda J,Kumar R,et al.Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor[].The Journal of Experimental Medicine.1998
-
9Kim Lee Sim B,O′Reilly MS,Anne HL,et al.A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer[].Cancer Research.1997
-
10Cao Y,Ji RW,Davidson D,et al.Kringle domains of human angiostatin[].Journal of Biological Chemistry.1996
同被引文献9
-
1邱达泰,黄芝,欧阳高亮,鲍仕登.肿瘤血管生成促进因子和抑制因子[J].中国药物与临床,2005,5(7):485-488. 被引量：6
-
2盛世乐,黄钢.VEGF上调survivin和bcl-2表达及抑制乳腺癌细胞凋亡的机制探讨[J].肿瘤,2005,25(6):525-529. 被引量：17
-
3Bouvet M, Ellis LM, Nishizaki M, et al. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res, 1998 ; 58 : 2288 - 2292
-
4Zhang L, Yu D, Hu M, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res,2000 ;60 : 3655 - 3661
-
5O'Reilly MS, Holmgren L , Shing Y, et al. Angiostatin: an novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell, 1994; 79:315 -318
-
6Katoh O,Takahashi T,Oguri T, et al. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res, 1998 ; 58:5565 - 5569
-
7Pidgeon GP, Barr MP, Harmey JH, et al. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer, 2001 ; 85:273 -278
-
8费嘉,张洹.血管内皮生长因子基因反义核酸的设计及其对K562细胞增殖的影响[J].中国病理生理杂志,2003,19(5):645-648. 被引量：11
-
9陈德喜,王申五,曹国栋,马丽萍,潘秀英.转导野生型p53的K562细胞出现生长抑制和凋亡[J].中国实验血液学杂志,1998,6(3):224-226. 被引量：3
-
1龚浩,宁军,谷俊朝.血管生成抑制素的研究进展[J].国际外科学杂志,2007,34(6):410-413. 被引量：1
-
2邵秋菊,袁梦晖,徐海峰.血管生成抑制素在实体瘤治疗中的研究进展[J].肿瘤防治杂志,2003,10(3):332-334. 被引量：2
-
3吴桂臣,罗荣城.血管生成抑制素和内抑素[J].肿瘤,2000,20(2):149-151. 被引量：3
-
4乔洪旺,康鹏程,田墨涵,张雅芳.血管生成抑制素对胃癌细胞的影响[J].解剖科学进展,2010,16(4):315-318. 被引量：1
-
5迟晓艳,邵旭建.血管生成抑制素和反应停对淋巴管内皮细胞生成的影响[J].解剖学杂志,2005,28(5):513-516. 被引量：4
-
6王炯,董承红.血管生成抑制素研究现状[J].国外医学（预防．诊断．治疗用生物制品分册）,1999,22(6):250-253.
-
7潘志刚,刘文超,孙宏邵,江澜,岳亚军,蔡伟,杨剑,薛安琳,刘汉山.血管生成抑制素对C6脑胶质瘤的抑瘤效应[J].肿瘤防治研究,2010,37(4):392-394. 被引量：1
-
8胡春洪,钱铭辉.脑部瘤周水肿的CT观察近展[J].国外医学（临床放射学分册）,1993,16(3):150-151. 被引量：9
-
9时德.胃肠道肿瘤化疗的近展[J].重庆医科大学学报,1992,17(3):236-239.
-
10张敦华.支气管类癌的近展[J].临床,1995,2(3):175-179.
